Atomistry » Fluorine » PDB 5hu9-5ifd » 5i7u
Atomistry »
  Fluorine »
    PDB 5hu9-5ifd »
      5i7u »

Fluorine in PDB 5i7u: Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor

Enzymatic activity of Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor

All present enzymatic activity of Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor:
3.4.14.5;

Protein crystallography data

The structure of Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor, PDB code: 5i7u was solved by G.Scapin, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 93.22 / 1.95
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 118.553, 126.545, 137.854, 90.00, 90.00, 90.00
R / Rfree (%) 15.4 / 18.7

Other elements in 5i7u:

The structure of Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor also contains other interesting chemical elements:

Sodium (Na) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor (pdb code 5i7u). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor, PDB code: 5i7u:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 5i7u

Go back to Fluorine Binding Sites List in 5i7u
Fluorine binding site 1 out of 2 in the Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F812

b:17.1
occ:1.00
F32 A:6AJ812 0.0 17.1 1.0
C3 A:6AJ812 1.3 15.6 1.0
C2 A:6AJ812 2.3 13.7 1.0
C4 A:6AJ812 2.3 12.9 1.0
CG2 A:VAL656 3.3 11.9 1.0
CH2 A:TRP659 3.3 17.0 1.0
CD2 A:TYR631 3.6 13.3 1.0
C1 A:6AJ812 3.6 14.4 1.0
C5 A:6AJ812 3.6 14.0 1.0
CZ3 A:TRP659 3.7 16.3 1.0
CA A:TYR631 3.8 12.3 1.0
CB A:TYR631 3.9 12.2 1.0
N A:TYR631 3.9 12.2 1.0
CE1 A:TYR666 4.0 14.3 1.0
C6 A:6AJ812 4.1 14.2 1.0
CG A:TYR631 4.1 13.0 1.0
CB A:VAL656 4.2 13.6 1.0
CE2 A:TYR662 4.3 13.9 1.0
CD2 A:TYR662 4.4 13.3 1.0
C A:SER630 4.5 14.8 1.0
CZ2 A:TRP659 4.5 16.6 1.0
CE2 A:TYR631 4.5 14.2 1.0
OH A:TYR666 4.6 18.1 1.0
CZ A:TYR666 4.6 18.8 1.0
CZ A:TYR662 4.6 15.3 1.0
CD1 A:TYR666 4.7 13.6 1.0
C15 A:6AJ812 4.8 12.5 1.0
CG1 A:VAL656 4.9 13.3 1.0
CG A:TYR662 4.9 13.0 1.0
O A:SER630 5.0 14.7 1.0
O14 A:6AJ812 5.0 14.9 1.0

Fluorine binding site 2 out of 2 in 5i7u

Go back to Fluorine Binding Sites List in 5i7u
Fluorine binding site 2 out of 2 in the Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human DPP4 in Complex with A Novel Tricyclic Hetero-Cycle Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F812

b:19.0
occ:1.00
F32 B:6AJ812 0.0 19.0 1.0
C3 B:6AJ812 1.3 16.9 1.0
C2 B:6AJ812 2.3 15.3 1.0
C4 B:6AJ812 2.4 16.6 1.0
CG2 B:VAL656 3.3 15.2 1.0
CH2 B:TRP659 3.4 16.2 1.0
CD2 B:TYR631 3.6 14.2 1.0
C1 B:6AJ812 3.6 14.0 1.0
C5 B:6AJ812 3.7 14.9 1.0
CZ3 B:TRP659 3.8 15.6 1.0
CA B:TYR631 3.9 12.5 1.0
N B:TYR631 3.9 12.8 1.0
CB B:TYR631 3.9 12.1 1.0
CE1 B:TYR666 4.1 17.9 1.0
C6 B:6AJ812 4.1 15.6 1.0
CG B:TYR631 4.1 13.4 1.0
CB B:VAL656 4.2 15.7 1.0
CE2 B:TYR662 4.3 12.2 1.0
CD2 B:TYR662 4.4 12.7 1.0
C B:SER630 4.5 16.6 1.0
CE2 B:TYR631 4.5 14.2 1.0
CZ2 B:TRP659 4.6 15.9 1.0
CZ B:TYR662 4.6 16.6 1.0
OH B:TYR666 4.6 17.1 1.0
CZ B:TYR666 4.6 21.3 1.0
CD1 B:TYR666 4.7 15.1 1.0
C15 B:6AJ812 4.7 12.9 1.0
O14 B:6AJ812 4.9 16.6 1.0
O B:SER630 4.9 14.9 1.0
CG B:TYR662 4.9 13.5 1.0
CG1 B:VAL656 5.0 15.0 1.0

Reference:

W.L.Wu, J.Hao, M.Domalski, D.A.Burnett, D.Pissarnitski, Z.Zhao, A.Stamford, G.Scapin, Y.D.Gao, A.Soriano, T.M.Kelly, Z.Yao, M.A.Powles, S.Chen, H.Mei, J.Hwa. Discovery of Novel Tricyclic Heterocycles As Potent and Selective Dpp-4 Inhibitors For the Treatment of Type 2 Diabetes. Acs Med.Chem.Lett. V. 7 498 2016.
ISSN: ISSN 1948-5875
PubMed: 27190600
DOI: 10.1021/ACSMEDCHEMLETT.6B00027
Page generated: Tue Jul 15 04:04:05 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy